CN101463374A - Bacillus dysenteriae diagnose reagent - Google Patents
Bacillus dysenteriae diagnose reagent Download PDFInfo
- Publication number
- CN101463374A CN101463374A CNA2007101156271A CN200710115627A CN101463374A CN 101463374 A CN101463374 A CN 101463374A CN A2007101156271 A CNA2007101156271 A CN A2007101156271A CN 200710115627 A CN200710115627 A CN 200710115627A CN 101463374 A CN101463374 A CN 101463374A
- Authority
- CN
- China
- Prior art keywords
- sodium
- culture
- diagnostic reagent
- dysentery bacillus
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a dysentery bacillus diagnostic reagent. The main components comprise tryptone, sodium citrate, sodium deoxycholate, monopotassium phosphate, dipotassium hydrogen phosphate, sodium chloride, calf serum, glucose and mannite which are processed to obtain the reagent by certain technology. The dysentery bacillus diagnostic reagent is used for feces enriched culture dysentery bacillus. The key to identifying the sort of bacteria by culture experiment is accuracy, high-speed and simpleness and convenience. The bacterination volume can affect the detection result directly. The enriched culture is always required to be carried out on a sample by different methods to identify the sort of the bacteria, which is the measure used most frequently in a microbiological laboratory. Due to the limit of the application range of the current culture condition, diagnostic reagent used for feces dysentery bacillus enriched culture is not specific and has the problems of large required inoculation volume, long culture time and proneness of showing false positive or false negative, etc. The dysentery bacillus diagnostic reagent has the advantages as follows: (1) the dysentery bacillus diagnostic reagent requires small inoculation volume and short culture time and can breed fast just by a small amount of bacterium; the result can be observed just after the culture for 5 to 6 hours at the normal room temperature or 37 DEG C; (2) the false positive or the false negative does not occur easily; and (3) the dysentery bacillus diagnostic reagent can destroy the bacteriostatic action of acheomycin, aureomycin, terramycin, neomycin, polymyxin and streptomycin existing in the sample.
Description
Technical field the present invention relates to a kind of bacillus dysenteriae diagnose reagent, and its main component is that Tryptones, Sodium Citrate, sodium deoxycholate, potassium primary phosphate, dipotassium hydrogen phosphate, sodium-chlor, calf serum, glucose, N.F,USP MANNITOL are made through certain technology.Use for ight soil and increase bacterium cultivation dysentery bacterium.Utilize culture experiment to differentiate the kind of bacterium, it is accurate, quick, easy that its key is.And the bacterial load size can directly influence detected result.Often need that sample is increased bacterium by different methods and cultivate, carry out the discriminating of bacterial species, this is the most frequently used means of present Microbiological Lab.Because at present the range of application of culture condition is limit, increasing the diagnostic reagent that bacterium cultivates for the ight soil dysentery bacterium does not have specific, has that required inoculum size is big, incubation time length, is prone to problems such as false positive or false negative.Along with the progress of biological study, increase the research of bacterium diagnostic reagent also in constantly developing to what bacterium was differentiated both at home and abroad.Biological worker wishes to have always and a kind ofly can overcome above-mentioned insufficient bacterium the diagnostic reagent----bacillus dysenteriae diagnose reagent that increases.
Background technology the object of the present invention is to provide and a kind ofly can overcome the existing insufficient bacillus dysenteriae diagnose reagent of differential diagnosis reagent.Similar diagnostic reagent with other is compared possesses following characteristics: required inoculum size is little, and a small amount of bacterium can breed rapidly, under room temperature usually or 37 ℃ cultivate and got final product observations in 5-6 hour; Be not prone to false positive and false negative; Can destroy the antibacterial substance that exists in the sample, bacterial growth is not suppressed.
Summary of the invention main points of the present invention are to select suitable component, and rationally are mixed, through heat, dissolve, technology such as mixing, cooling, packing, high-temperature sterilization forms a kind of bacillus dysenteriae diagnose reagent.
The prescription following (component and weight percent % thereof) that the present invention selects: Tryptones (1.8-2.2), Sodium Citrate (0.4-0.5), sodium deoxycholate (0.04-0.06), potassium primary phosphate (0.14-0.16), dipotassium hydrogen phosphate (0.38-0.42), sodium-chlor (0.4-0.5), glucose (0.10-0.12), N.F,USP MANNITOL (0.15-0.25), calf serum (0.4-0.5), distilled water add to 100ml.
This diagnostic reagent contains Sodium Citrate and sodium deoxycholate, and Gram-negative bacteria is had restraining effect, intestinal bacteria, and Pseudomonas aeruginosa and Bacillus proteus, poor growth in inoculating 6 hours, and dysentery bacterium can relatively obtain propagation. sodium-chlor is used to adjust osmotic pressure; Potassium primary phosphate is used to regulate pH.Tryptones, calf serum, glucose, N.F,USP MANNITOL are the nutrition in the diagnostic reagent and support composition.Be computing time after the specimen inoculation, under common room temperature or 37 ℃ of cultivations, the bacterium of increasing effect arranged all. increase bacterium and cultivate after 6 hours, promptly with the method for scoring culture transferring to the enteron aisle selectivity diagnostic reagent to separate pathogenic bacterium.
The preparation method of product of the present invention is:
1), Tryptones, Sodium Citrate, sodium deoxycholate, potassium primary phosphate, dipotassium hydrogen phosphate, sodium-chlor, glucose, N.F,USP MANNITOL are added in the distilled water in proportion, the reheat dissolving is corrected pH to 7.0 and is corrected pH to 6.8, uses filter paper filtering;
2), pressuresteam sterilization 0.70kg15 minute;
3), under the aseptic condition, add aseptic calf serum, packing ampere bottle, every bottle of about 5ml is stored in the refrigerator standby.
The present invention has the following advantages: (1) required inoculum size is little, and incubation time is short, and a small amount of bacterium can breed rapidly, under room temperature usually or 37 ℃ cultivate and got final product observations in 5-6 hour; (2) be not prone to false positive or false negative; (3) can destroy the bacteriostatic action of the tsiklomitsin, duomycin, terramycin, Xin Meisu, polymyxin and the Streptomycin sulphate that exist in the sample.
The present invention is described in further detail below in conjunction with embodiment for embodiment:
Be configured according to following table institute column data (weight percent %) and described step thereof:
Prescription one:
Tryptones 1.8-2.2
Sodium Citrate 0.4-0.5
Sodium deoxycholate 0.04-0.06
Potassium primary phosphate 0.14-0.16
Dipotassium hydrogen phosphate 0.38-0.42
Sodium-chlor 0.4-0.5
Glucose 0.10-0.12
N.F,USP MANNITOL 0.15-0.25
Calf serum 0.4-0.5
Distilled water adds to 100
Prescription two:
Tryptones 1.8-2.0
Sodium Citrate 0.4-0.45
Sodium deoxycholate 0.04-0.05
Potassium primary phosphate 0.14-0.15
Dipotassium hydrogen phosphate 0.38-0.40
Sodium-chlor 0.4-0.45
Glucose 0.10-0.11
N.F,USP MANNITOL 0.15-0.20
Calf serum 0.4-0.45
Distilled water adds to 100
Prescription three:
Tryptones 2.0-2.2
Sodium Citrate 0.45-0.5
Sodium deoxycholate 0.05-0.06
Potassium primary phosphate 0.15-0.16
Dipotassium hydrogen phosphate 0.40-0.42
Sodium-chlor 0.45-0.5
Glucose 0.11-0.12
N.F,USP MANNITOL 0.18-0.25
Calf serum 0.45-0.5
Distilled water adds to 100
Prescription four:
Tryptones 1.9-2.1
Sodium Citrate 0.42-0.45
Sodium deoxycholate 0.05-0.06
Potassium primary phosphate 0.15-0.16
Dipotassium hydrogen phosphate 0.39-0.40
Sodium-chlor 0.42-0.45
Glucose 0.11-0.12
N.F,USP MANNITOL 0.17-0.22
Calf serum 0.42-0.45
Distilled water adds to 100.
Claims (2)
1, a kind of bacillus dysenteriae diagnose reagent is to be main component with Tryptones, Sodium Citrate, sodium deoxycholate, potassium primary phosphate, dipotassium hydrogen phosphate, sodium-chlor, calf serum, glucose, N.F,USP MANNITOL; It is characterized in that having following prescription (component and weight percent % thereof): Tryptones (1.8-2.2), Sodium Citrate (0.4-0.5), sodium deoxycholate (0.04-0.06), potassium primary phosphate (0.14-0.16), dipotassium hydrogen phosphate (0.38-0.42), sodium-chlor (0.4-0.5), glucose (0.10-0.12), N.F,USP MANNITOL (0.15-0.25), calf serum (0.4-0.5), distilled water 100ml.
2, the preparation method of the described bacillus dysenteriae diagnose reagent of a kind of claim 1 is characterized in that having following step:
1), Tryptones, Sodium Citrate, sodium deoxycholate, potassium primary phosphate, dipotassium hydrogen phosphate, sodium-chlor, glucose, N.F,USP MANNITOL are added in the distilled water in proportion, the reheat dissolving is corrected pH to 7.0 and is corrected pH to 6.8, uses filter paper filtering;
2), pressuresteam sterilization 0.70kg15 minute;
3), under the aseptic condition, add aseptic calf serum, packing ampere bottle, every bottle of about 5ml is stored in the refrigerator standby.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101156271A CN101463374A (en) | 2007-12-18 | 2007-12-18 | Bacillus dysenteriae diagnose reagent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101156271A CN101463374A (en) | 2007-12-18 | 2007-12-18 | Bacillus dysenteriae diagnose reagent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101463374A true CN101463374A (en) | 2009-06-24 |
Family
ID=40804164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101156271A Pending CN101463374A (en) | 2007-12-18 | 2007-12-18 | Bacillus dysenteriae diagnose reagent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101463374A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103014119A (en) * | 2011-09-21 | 2013-04-03 | 宋旭岩 | Rapid diagnosis reagent for pathogenic bacillus dysenteriae in medical institution sewage |
CN103194522A (en) * | 2012-01-05 | 2013-07-10 | 曲剑英 | Rapid detection reagent of pathogens in foodstuff and cosmetic enterprises |
-
2007
- 2007-12-18 CN CNA2007101156271A patent/CN101463374A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103014119A (en) * | 2011-09-21 | 2013-04-03 | 宋旭岩 | Rapid diagnosis reagent for pathogenic bacillus dysenteriae in medical institution sewage |
CN103194522A (en) * | 2012-01-05 | 2013-07-10 | 曲剑英 | Rapid detection reagent of pathogens in foodstuff and cosmetic enterprises |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Edelstein et al. | Legionnaires’ disease: a review | |
Inglis et al. | Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei | |
JPH074272B2 (en) | Specific medium for detecting microorganisms | |
US11732237B2 (en) | Microbiological growth media and methods of using the same | |
Haag et al. | Molecular diagnosis of microbial aetiologies using SepsiTest™ in the daily routine of a diagnostic laboratory | |
CN106460030A (en) | Composition and method for stabilizing and maintaining the viability of hardy microorganisms | |
Yoon et al. | Detecting bacterial growth in continuous ambulatory peritoneal dialysis effluent using two culture methods | |
Sun et al. | Development of a novel LAMP diagnostic method for visible detection of swine Pasteurella multocida | |
Yagupsky et al. | Outbreaks of invasive Kingella kingae infections in daycare facilities: approach to investigation and management | |
CN100392096C (en) | Two phase Roe's culture medium and preparation method thereof | |
CN102337344A (en) | Quantitative detection method of escherichia coli in soil and assay kit thereof | |
CN101089174A (en) | Gram-negative bacillus proliferating culture medium | |
CN101463374A (en) | Bacillus dysenteriae diagnose reagent | |
CN104673885A (en) | Detection kit and detection method for I-form legionella pneumophila | |
Corney et al. | Rapid and sensitive detection of Avibacterium paragallinarum in the presence of other bacteria using a 5′ Taq nuclease assay: a new tool for diagnosing infectious coryza | |
Ciragil et al. | Evaluation of a new chromogenic medium for isolation and identification of common urinary tract pathogens | |
Khosroshahi et al. | Identification of Legionella pneumophila in intubated patients with TaqMan real time PCR | |
CN101089190A (en) | Nutrition blood culture medium | |
CN101565734A (en) | Neutralization antibiotic nutritional blood culture medium | |
CN101591695A (en) | The sodium lauryl sulphate neutralization increases bacterial context soup | |
Mentula et al. | Legionella longbeachae infection in a persistent hand-wound after a gardening accident | |
Hansen | Laboratory blood cultures: past, present, and future | |
CN101698875A (en) | Feces bacterium-supplemented dysentery bacillus culture medium | |
CN102827795A (en) | Culture medium for enriching salmonella, shigella and staphylococcus aureus in composite way and preparation method thereof | |
CN112831539A (en) | In-vitro detection kit for aerobic microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090624 |